MYCIO Wealth Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History

MYCIO Wealth Partners’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-500	Closed	-$19K	–	1142
2016 Q2	$19K	Hold	500	–	–	﹤0.01%	471
2016 Q1	$19K	Hold	500	–	–	﹤0.01%	447
2015 Q4	$22K	Hold	500	–	–	﹤0.01%	412
2015 Q3	$20K	Hold	500	–	–	﹤0.01%	455
2015 Q2	$27K	Hold	500	–	–	0.01%	389
2015 Q1	$30K	Buy	+500	New	+$24.3K	0.01%	352

Other funds holding JUNO

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

MYCIO Wealth Partners's JUNO Position: Q3 2016 in Review

MYCIO Wealth Partners sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2016, closing a stake of 500 shares — an estimated $19K sold.

MYCIO Wealth Partners first reported a position in JUNO in Q1 2015 and held it in 6 quarters. The position peaked at $30K in Q1 2015. 169 funds tracked by Wall St. Rank hold JUNO as of Q3 2016.

MYCIO Wealth Partners reported no remaining Juno Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 500 Juno Therapeutics, Inc. shares in Q3 2016, an estimated $19K.
MYCIO Wealth Partners first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 6 quarters.
MYCIO Wealth Partners's Juno Therapeutics, Inc. position peaked at $30K in Q1 2015.
169 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2016.

Based on MYCIO Wealth Partners's 13F filing for Q3 2016, filed 3 Nov 2016.